September 2004
NIH/National Institute of Mental Health
Chemical signals health of brain cells – SymposiumThe "First International Symposium on N-acetylaspartate," (NAA), will be held September 13-14, 2004 at the National Institutes of Health Natcher Conference Center, Bethesda, MD. NAA is best known as a marker for the health of neurons, brain cells, which can be measured non-invasively, using magnetic resonance spectroscopy (MRS).
The meeting brings together basic researchers and clinicians from around the world to discuss all aspects of NAA, a highly abundant and nervous system-specific amino acid derivative. The different topics of discussion include: - Biochemistry and cell biology of NAA
- Pathogenesis and treatment of Canavan disease
- Use of NAA as a neuronal integrity marker for neurological diseases by magnetic resonance spectroscopy
- N-acetylaspartylglutamate, the most abundant mammalian peptide neurotransmitter.
The first comprehensive meeting ever held on NAA, the Symposium features presentations by leading investigators and a poster session. The meeting is organized by the National Institute of Mental Health and is co-sponsored by the National Institute of Neurological Disorders and Stroke, the National Institute of Child Health and Human Development, and the Office of Rare Diseases at the National Institutes of Health (NIH).
Agenda and further information: http://www.betah.com/conferences/NAA2004/index.html
Program contacts:
Dr. Aryan Namboodiri, Uniformed Services University of the Health Sciences 301-295-3516, [email protected]
Shari Thompson, NIMH Clinical Brain Disorders Branch 301-451-2293, [email protected]
Dr Giovanna Spinella, Office of Rare Diseases 301-402-4336, [email protected]
Dr. Steve Groft, Office of rare Diseases 301-402-4336, [email protected]
Dr. Dan Tagle, NINDS 301-496-5745, [email protected]
Dr. James Hanson, NICHD 301-496-8535, [email protected]
Contacts: NIMH
301-443-4536
NINDS
301-496-5924
NICHD
301-496-5133
OD
301-435-7841
| |
|